BF
Bita Farrokhroo
Founder And Ceo at Medwatchers
View Bita's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Founder And Ceo
Present
Company Details
51-200 Employees
MedWatchers provides high-quality, creative MTM solutions to optimize medication therapy, improve health outcomes, and control healthcare costs. Our team of culturally competent pharmacists speaks 30 different languages and our clients have referred to us as ‘the magic bullet’ for patient engagement who consistently year after year not only deliver results but exceed expectations. MedWatchers’ technology-advanced, proprietary platform, CMAPP, enables pharmacists to deliver safe, efficient, and effective clinical services. CMAPP is HITRUST-certified, customizable, and is available for leasing to support SaaS or Hybrid model needs. It leverages an advanced clinical engine and library as well as predictive analytics to optimize outreach via phone, telehealth, SMS, and interactive solutions. Our programs include Star and HEDIS measures (MTM, adherence, SUPD/SPC, COA, medication reconciliation, polypharmacy), SDOH, chronic disease management programs (Diabetes, COPD/Asthma, CHF), pharmacogenomics, and more. Each program can be customized to meet clients’ clinical, operational, and branding needs to ensure optimized performance on all quality measures.
Year Founded
2010
Social Media
Linkedin
Industry
Hospitals and Health Care, Specialty (except Psychiatric and Substance Abuse) Hospitals, Health Care and Social Assistance
HQ Location
11975 El Camino Real Suite 101 San Diego, California 92130, US
Keywords
Comprehensive Medication ReviewMulti-lingual pharmacistsOptimize therapeutic outcomesControl medication costsImproved health care outcomesDrug InteractionsHigh risk medicationsAdherenceStar RatingsPharmacogenomics
Discover More About Cleveland Clinic

Find verified contacts of Bita Farrokhroo in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.